文献速递免疫规划传染病防控与疫情报告

波兰国家免疫规划实施结合疫苗后婴幼儿侵袭性疾病肺炎链球菌种群变化

Changes in the Streptococcus pneumoniae population responsible for invasive disease of young children after the implementation of conjugated vaccines in the National Immunization Program in Poland.
PubMed 文献 · Vaccine · 2025-09-19

研究涵盖2014至2020年波兰两岁以下儿童实验室确诊侵袭性肺炎链球菌病病例,比较PCV10纳入国家免疫规划前后菌株血清型、耐药与基因组特征。PCV10疫苗型从56.9%降至29.5%,而含于高价疫苗的3、6A、19A型从17.6%升至25.7%,非疫苗型从12.8%升至22.9%;青霉素耐药从49.0%降至34.3%,红霉素耐药从55.9%降至41.9%,多重耐药从46.1%降至30.5%,菌毛阳性从50.0%降至28.6%。

要点

  • PCV10纳入波兰国家免疫规划后,疫苗型菌株占比由56.9%降至29.5%。
  • 高价疫苗覆盖的3、6A、19A型占比由17.6%升至25.7%,非疫苗型由12.8%升至22.9%。
  • 青霉素耐药由49.0%降至34.3%,多重耐药由46.1%降至30.5%。

核心结论

  • PCV10纳入波兰国家免疫规划后前三年,PCV10疫苗型流行率显著下降,GPSC组成变化与多重耐药及菌毛相关高毒力菌株感染减少相关联,需持续监测肺炎链球菌演变。

研究设计与样本

  • 研究涵盖2014至2020年波兰两岁以下儿童所有实验室确诊侵袭性肺炎链球菌病病例,分为PCV前阶段(2014-2016年)和PCV后阶段(2017-2020年)。
  • 采用标准方法进行菌株鉴定、血清分型和抗菌药物敏感性检测,所有肺炎链球菌分离株进行全基因组测序和分析。

主要发现

  • PCV10引入后,PCV10疫苗型菌株流行率从56.9%降至29.5%。
  • 同时,含于高价结合疫苗的额外三种血清型(3、6A和19A)从17.6%升至25.7%,非疫苗血清型从12.8%升至22.9%。
  • 青霉素耐药率从49.0%降至34.3%,红霉素耐药率从55.9%降至41.9%,多重耐药菌株占比从46.1%降至30.5%,菌毛阳性分离株占比从50.0%降至28.6%。
  • PCV前阶段全球肺炎链球菌序列簇(GPSC)GPSC1最常见(17.6%),PCV后阶段GPSC12最常见(10.5%),特定血清型(如14和19A)内GPSC组成也发生变化。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In Poland, 10-valent pneumococcal conjugate vaccine (PCV10) was added to the National Immunization Program (NIP) in 2017. We aimed to investigate the population structure and genomic composition of pneumococcal strains responsible for invasive infections in young children before and after the introduction of PCV10 to the NIP. METHODS: The study encompassed all laboratory-confirmed cases of invasive pneumococcal disease between 2014 and 2020 in Polish children under the age of two. This period was split into two phases: the pre-PCV period (2014-2016) and the post-PCV period (2017-2020). Standard methods were utilized for identifying, serotyping, and testing the antimicrobial susceptibility of the isolates. All S. pneumoniae isolates underwent whole genome sequencing and analysis. RESULTS: Following the introduction of PCV10, the prevalence of PCV10 vaccine-type (PCV10-VT) strains decreased significantly from 56.9 % to 29.5 %. Concurrently, the additional three serotypes present in higher valency PCVs (3, 6A and 19A), increased from 17.6 % to 25.7 %, and non-vaccine serotypes from 12.8 % to 22.9 %. A significant decline was observed in resistance to penicillin (49.0 %-34.3 %), and erythromycin (55.9 %-41.9 %), in the percentage of multidrug-resistant (46.1 %-30.5 %), and pilliated isolates (50.0 %-28.6 %). In the pre-PCV period, Global Pneumococcal Sequence Cluster (GPSC), GPSC1 was the most prevalent (17.6 %), and in the post-PCV period GPSC12 emerged as the most common (10.5 %). Changes in the GPSC composition within particular serotypes (e.g. 14 and 19A) were also observed. CONCLUSIONS: In the first three years after the introduction of the PCV10 into the Polish NIP significant reduction in the prevalence of PCV10-VTs was observed. Molecular characterization of the studied population allowed us to link the observed changes in the GPSC prevalence, with a decrease of infections caused by multi-drug resistant pneumococci and those with higher virulence associated with the presence of pili. The consistent evolution of S. pneumoniae influenced by population-based vaccinations, requires continuous surveillance.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Wróbel-Pawelczyk I, Gołębiewska A, Ronkiewicz P, et al. Changes in the Streptococcus pneumoniae population responsible for invasive disease of young children after the implementation of conjugated vaccines in the National Immunization Program in Poland. Vaccine. 2025. PMID: 40974736. doi:10.1016/j.vaccine.2025.127759

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。